Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04158934 · ClinicalTrials.gov registry record
A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A
A clinical trial of Hemophilia A, sponsored by Baxalta now part of Shire.
- Active
- Registry status
- 207
- Enrollment target
- 20
- Study locations
NCT04158934 is a study of Hemophilia A that is active but no longer recruiting, run by Baxalta now part of Shire. The registered enrollment target is 207 participants, above the 87-participant average among 42 other Hemophilia A trials with a reported enrollment target (138% higher). The trial reports 20 study locations across 3 states.
The verdict
NCT04158934, a study of Hemophilia A, is active but no longer recruiting, sponsored by Baxalta now part of Shire.
- ACTIVE NOT RECRUITING
- Registry status
- 207 participants
- Enrollment target
- 20
- Study locations
Study Summary
The main aim of this study is to check for long-term side effects from ADYNOVI/ADYNOVATE prophylaxis in participants with haemophilia A when used under standard clinical practice in the real-world clinical setting.
Conditions Studied
Interventions
- BIOLOGICAL ADYNOVI/ADYNOVATE
Study Locations (20)
Other
- SHAT of Oncohaematology Diseases - Sofia
- Clinical Hospital Sveti Duh - Zagreb
- University hospital centre Zagreb - Zagreb
- University hospital centre Zagreb - Zagreb
- Fakultni nemocnice v Motole - Prague
- Krajska zdravotni a.s. - Masarykova nemocnice v Usti nad Labem o.z. - Ústí nad Labem
- Vivantes Klinikum im Friedrichshain - Berlin
- Universitaetsklinikum Bonn AoeR - Bonn
- Werlhof-Institut GmbH - Hanover
- Heim Pal Orszagos Gyermekgyogyaszati Intezet - Budapest
- Eszak-Pesti Centrumkorhaz - Honvedkorhaz - Budapest
- Debreceni Egyetem - Debrecen
- Mohacsi Korhaz - Mohács
- Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz - Nyíregyháza
- Pecsi Tudomanyegyetem Klinikai Kozpont - Pécs
- Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico - Milan
- Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza - Roma
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Roma
Florida
- UF Health Shands Hospital - Gainesville
Baden-Wurttemberg
- SRH Kurpfalzkrankenhaus Heidelberg GmbH - Heidelberg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2020-07-09 |
| Est. Completion | 2030-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04158934
The ClinicalTrials.gov registry entry for NCT04158934 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 87-participant average among 42 other Hemophilia A trials with a reported enrollment target (138% higher). The listed sponsor is Baxalta now part of Shire, which has 74 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemophilia A appearing as the primary indexed condition, and to 1 intervention - of which ADYNOVI/ADYNOVATE is the first listed.
NCT04158934 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Other, Florida, Baden-Wurttemberg.
Frequently Asked Questions
What is clinical trial NCT04158934 about?
NCT04158934 is a clinical study titled "A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A". The main aim of this study is to check for long-term side effects from ADYNOVI/ADYNOVATE prophylaxis in participants with haemophilia A when used under standard clinical practice in the real-world clinical setting.
What is the current status of trial NCT04158934?
This trial is currently active not recruiting. The enrollment target is 207 participants. The study started on 2020-07-09. Estimated completion is 2030-02-28.
What conditions does trial NCT04158934 study?
This clinical trial studies the following conditions: Hemophilia A.
What interventions are being tested in trial NCT04158934?
The interventions under investigation include: ADYNOVI/ADYNOVATE (BIOLOGICAL).
Who is sponsoring clinical trial NCT04158934?
This trial is sponsored by Baxalta now part of Shire, which has 74 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04158934 being conducted?
This trial has 20 study locations across Florida, Baden-Wurttemberg. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophilia A
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
RECRUITING · Phase 3
-
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
RECRUITING · Phase 3
-
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
RECRUITING · Phase 1
-
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
RECRUITING · Phase 4
-
Hemophilia A Research Program
RECRUITING
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.